The high-tech double-barrel nanopipette for the first time enabled researchers to see how individual living cancer cells react to treatment and change over time - providing vital understanding that could help doctors develop more effective cancer medication.
Researchers explore the potential of porous silicon nanotube bundles as nanocarriers for delivering small interfering RNA (siRNA) into cells, achieving around 50% knockdown of a target protein. This drug delivery approach holds promise for RNA therapeutics.
